CIK 0000313143
- Large accelerated filer
HAEMONETICS CORP
Sign in to watch- Ticker
- HAE
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Apr 3
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 042882273
- Phone
- +1 781-848-7100
- Business address
- 125 SUMMER STREET, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $101,148
- in 1 filing
Net −$101,148. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-01-13 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Grant or award | +11,393 | $0.01 | $114 | 56,743 |
| 2015-10-26 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Sale | −436 | $32.13 | $14K | 45,350 |
| 2015-10-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Grant or award | +6,255 | $0.01 | $63 | 44,443 |
| 2015-10-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Grant or award · Non-qualified Stock Option (Right to Buy) | +27,498 | $31.97 | $879K | 27,498 |
| 2015-10-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Grant or award · Performance Shares | +12,511 | 12,511 | ||
| 2015-08-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Exercise or conversion | +4,902 | $26.32 | $129K | 43,090 |
| 2015-08-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Sale | −4,902 | $38.49 | $189K | 38,188 |
| 2015-08-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −4,902 | $38.49 | $189K | 0 |
| 2015-07-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Exercise or conversion | +4,902 | $26.32 | $129K | 43,090 |
| 2015-07-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Sale | −4,902 | $39.09 | $192K | 38,188 |
| 2015-07-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −4,902 | $39.09 | $192K | 4,902 |
| 2015-06-22 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Exercise or conversion | +4,902 | $26.32 | $129K | 43,090 |
| 2015-06-22 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Sale | −4,902 | $42.51 | $208K | 38,188 |
| 2015-06-22 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −4,902 | $42.51 | $208K | 9,804 |
| 2015-05-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Exercise or conversion | +4,902 | $26.32 | $129K | 43,090 |
| 2015-05-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Sale | −4,902 | $41.65 | $204K | 38,188 |
| 2015-05-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −4,902 | $26.32 | $129K | 14,706 |
| 2015-04-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Exercise or conversion | +4,902 | $26.32 | $129K | 42,735 |
| 2015-04-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Sale | −4,902 | $41.55 | $204K | 37,833 |
| 2015-04-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −4,902 | $41.55 | $204K | 19,608 |
Page 1 of 3 · 42 trades